Literature DB >> 5094342

Erythromycin concentrations in middle ear exudates.

J W Bass, R W Steele, R A Wiebe, E P Dierdorff.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5094342

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


× No keyword cloud information.
  11 in total

Review 1.  Clinical pharmacokinetic properties of the macrolide antibiotics. Effects of age and various pathophysiological states (Part II).

Authors:  P Periti; T Mazzei; E Mini; A Novelli
Journal:  Clin Pharmacokinet       Date:  1989-05       Impact factor: 6.447

2.  Penetration of ceftibuten into middle ear fluid.

Authors:  C Lin; P Kumari; R J Perrotta; B E Reidenberg
Journal:  Antimicrob Agents Chemother       Date:  1996-06       Impact factor: 5.191

Review 3.  Rational prescribing of antibacterials in ambulatory children.

Authors:  J E Hoppe
Journal:  Pharmacoeconomics       Date:  1996-12       Impact factor: 4.981

Review 4.  Acute otitis media: diagnosis and drug therapy.

Authors:  R H Schwartz; D M Schwartz
Journal:  Drugs       Date:  1980-02       Impact factor: 9.546

5.  [Tissue penetration of erythromycin (author's transl)].

Authors:  G A Dette
Journal:  Infection       Date:  1979       Impact factor: 3.553

6.  In vitro activity of antibiotics commonly used in the treatment of otitis media against Streptococcus pneumoniae isolates with different susceptibilities to penicillin.

Authors:  M M Tarpay; D F Welch; H Salari; M I Marks
Journal:  Antimicrob Agents Chemother       Date:  1982-07       Impact factor: 5.191

7.  In vitro activity of orally administered antimicrobial agents against Haemophilus influenzae recovered from children monitored longitudinally in a group day-care center.

Authors:  M J George; B Kitch; F W Henderson; P H Gilligan
Journal:  Antimicrob Agents Chemother       Date:  1991-10       Impact factor: 5.191

8.  Acute mastoiditis--relevant once again.

Authors:  J E Hoppe; S Köster; F Bootz; D Niethammer
Journal:  Infection       Date:  1994 May-Jun       Impact factor: 3.553

9.  In vitro activity of the new macrolide antibiotic roxithromycin (RU 28965) against clinical isolates of Haemophilus influenzae.

Authors:  J H Jorgensen; J S Redding; A W Howell
Journal:  Antimicrob Agents Chemother       Date:  1986-05       Impact factor: 5.191

10.  Susceptibility testing of macrolide antibiotics against Haemophilus influenzae and correlation of in vitro results with in vivo efficacy in a mouse septicemia model.

Authors:  P B Fernandes; D Hardy; R Bailer; E McDonald; J Pintar; N Ramer; R Swanson; E Gade
Journal:  Antimicrob Agents Chemother       Date:  1987-08       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.